Xarelto Lawsuit Iphone Apps
Our attorneys have filed a mass tort lawsuit on behalf of individuals who took the blood thinner Xarelto (rivaroxaban) and suffered severe bleeding events. Pharmaceutical firms, like the makers of Xarelto, have a duty to ensure that their drugs are reasonably secure for use - and failure to perform so could be grounds for compensation. Our lawyers are operating difficult to have those hurt by the drug the compensation they're entitled to.
Although bleeding is a widespread complication linked with anticoagulants, it has been alleged that Xarelto is more hazardous than standard blood thinners because no antidote exists to reverse its blood-thinning effects. This implies that, within the event of an emergency, sufferers may be at risk for irreversible bleeding difficulties, including life-threatening internal and gastrointestinal hemorrhaging.
Should you or even a loved 1 suffered a critical bleeding event right after taking Xarelto, you might have legal recourse. For a lot more info, contact us nowadays to possess your case reviewed, free of charge.
Compensation Possibilities
xarelto-compensation-photoThe plaintiffs in these lawsuits are searching for compensation from Bayer and Janssen for previous and future healthcare bills, lost wages, pain and suffering and, in circumstances of death, funeral expenses. Furthermore, they are in search of punitive damages, that are generally awarded to punish the defendant and deter other firms from acting similarly.
Why Are Lawsuits Being Filed?
Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is hazardous and defective. The plaintiffs claim that, unlike classic anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Due to the fact of this, the lawsuits claim, doctors have no effective indicates of stopping Xarelto users from bleeding inside the event of an emergency. Plaintiffs in the lawsuits allege significant and fatal injuries, which includes cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.
In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:
The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a secure anticoagulant option.
Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user within the occasion of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.
Xarelto is linked to severe bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing hazardous clotting.
Visit this page for more info on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set
The attorneys in the Complex Litigation Group have filed lawsuits on behalf of injured clients. click the following article claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.